KCT0004052Recruiting未知
A comparative clinical trial to evaluate the efficacy and safety of 'Hwangryenhaedogtang‘ in treatment of gastritis
Pusan National University Korean Medicine Hospital0 sites20 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 20
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional Study
Eligibility Criteria
- Ages
- 19(Year) to 65(Year) (—)
- Sex
- All
Inclusion Criteria
- •1) Only those aged 19 or over but under 65
- •2) Body mass index (BMI) of more than 25 kg / m2
- •3) Those who have been diagnosed with gastritis by gastroscopy
- •4) After fully hearing and understanding the details of this clinical trial, you agree to participate voluntarily and agree in writing to abide by the instructions.
- •5) Those who can follow up during the clinical trial
Exclusion Criteria
- •1) Those who can not undergo gastroscopy
- •2) peptic ulcer (except patients with scarring)
- •3) Those who have had past gastric acid secretion surgery or stomach and esophagus surgery
- •4) A person with a history of gastrointestinal malignancies
- •5) In the second week prior to administration of test drug, H2 receptor antagonist, anticholinergic agent (muscarinic receptor antagonist), gastrin receptor antagonist, prostaglandin agent, proton pump inhibitor, gastric mucosal protective agent, One who took it
- •6) Those who need to continue taking medications that may affect this test, such as corticosteroids, non-steroidal anti-inflammatory drugs, and aspirin
- •7) Those taking thrombolytic agents (such as cerebral thrombosis, myocardial infarction, thrombophlebitis), consuming coagulation disorder patients and antithrombotic agents such as warfarin
- •8) People with Zollinger-Ellison syndrome
- •9) Those with a history of drug allergy symptoms (rash, fever, itching, etc.)
- •10) Patients with abnormal liver function and renal function with serum AST, ALT and creatinine> 3 times the normal peak
- •11) Those who have serious obstacles such as liver, kidney, heart, lung, blood
- •12) Those who are pregnant or breastfeeding, those who are pregnant, those who have a pregnancy plan or do not agree to the appropriate method of contraception
- •13) Those who have severe mental illnesses such as depression, anxiety disorder, or are currently taking psychotropic drugs such as antidepressants
- •14) Drug or alcohol addict
- •15) Those taking medicines or health functional foods that may affect the clinical trial
- •16) Smokers whose average daily smoking amount exceeds 10 per day during the past 3 months
- •17) Those who continue to drink (21 units / week, 1 unit = 10 g of pure alcohol)
- •Example> Beer 5 ° 1 cup (250 ml) = 10 g, soju 20 ° 1 cup (50 ml) = 8 g, wine 12 ° 1 cup (125 ml) = 12 g
- •18) Any person judged by the examiner to be inappropriate for other examinations
Investigators
Similar Trials
Not yet recruiting
Phase 2
Management of Arsha (Piles/ Haemorrhoids) by Kshara application in AyurvedaCTRI/2017/12/010775All India Institute of Ayurveda
Not yet recruiting
Phase 2
A clinical trial to study the effects of two drugs, eranda suppository & diclofenac suppository in patients with post operative haemorrhoidectomy paiCTRI/2023/07/055787Dr Yogesh Kanna V
Not yet recruiting
Phase 2
Efficacy study of castor oil as purgative at two different administration time as before dinner and at bed time in management of constipation.CTRI/2021/12/038769Sane Guruji Arogya kendra
Not yet recruiting
Unknown
A clinical study to see the effect of Ayurvedic formulation in the form of oral administration in the treatement of Galagraha with reference to acute pharyngitis.CTRI/2024/05/067260Sane Guruji Arogya Kendra
Not yet recruiting
Phase 1
Ayurvedic management ofAnemia in school going childreCTRI/2019/05/019217Parul Institute of Ayurved